We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Regulatory News: GeNeuro (Euronext Paris : CH0308403085 - GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...
Phase 2 clinical trial of temelimab against neuropsychiatric syndromes of Post-COVID (GNC-501): Recruitment completed in November 2023; Topline results planned for end of June 2024. Cash...
81,4% du capital social de la société était représenté à l'assemblée générale et les résolutions ont toutes été approuvées à l’unanimité Regulatory News: GeNeuro (Euronext Paris : CH0308403085 –...
Le présent communiqué n’est pas une communication à caractère promotionnel et ne constitue pas un prospectus au sens du Règlement (UE) 2017/1129 Regulatory News: NE PAS PUBLIER, DISTRIBUER OU...
Regulatory News: NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER...
Cash position of €2.8 million, including €1 million of Research Tax Credit pre-financing implemented in early January 2024 Capital increase designed to secure funding for completion of...
Regulatory News: GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on stopping the progression of neurodegenerative and autoimmune diseases such as multiple...
Comme prévu initialement dans le protocole de l’étude, le Comité Indépendant de Surveillance des Données (IDMC – Independant Data Monitoring Committee) s’est réuni afin d’examiner les données de...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.025 | 1.71232876712 | 1.46 | 1.525 | 1.45 | 7775 | 1.484604 | DE |
4 | 0.025 | 1.71232876712 | 1.46 | 1.525 | 1.4 | 5145 | 1.4642384 | DE |
12 | 0.385 | 35 | 1.1 | 1.53 | 1.065 | 5631 | 1.35031439 | DE |
26 | 0.425 | 40.0943396226 | 1.06 | 1.7 | 0.95 | 6463 | 1.26514309 | DE |
52 | -0.365 | -19.7297297297 | 1.85 | 1.99 | 0.94 | 5860 | 1.33960044 | DE |
156 | -2.515 | -62.875 | 4 | 4.39 | 0.94 | 5469 | 2.43530908 | DE |
260 | -2.495 | -62.6884422111 | 3.98 | 6.28 | 0.94 | 5552 | 3.03958471 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions